Jun 15, 2020
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
May 28, 2020
phiGenomics - Advanced DNA Diagnostics For Legionella from Phigenics
May 14, 2020
Armata Pharmaceuticals Announces First Quarter 2020 Results and Provides General Corporate Update
May 06, 2020
Antabio Receives QIDP Designation From the U.S. FDA for the Development of MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO's Priority Pathogens
Apr 27, 2020
Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ
Mar 19, 2020
Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Results and Provides General Corporate Update
Mar 05, 2020
Legionella Water Management Plans at Your Fingertips
Mar 03, 2020
Pritzker Hageman Legionnaires' Disease Lawyers Representing Victim in Arlington Court Legionnaires' Outbreak
Feb 19, 2020
Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Pipeline Insight, 2020
Jan 15, 2020
Bloom Science Granted Exclusive Option to License Microbiome-Based Technology for the Development of Novel Treatments for Multiple Neurological and Oncology Conditions
Dec 19, 2019
AOAC approves Neogen's Soleris® for Enterobacteriaceae
Nov 12, 2019
Armata Pharmaceuticals Announces Third Quarter Results and Provides Corporate and Clinical Update
Oct 31, 2019
Armata Pharmaceuticals Issues Letter to Shareholders
Oct 22, 2019
Qpex Biopharma and Brii Biosciences Enter Into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China
Sep 30, 2019
BiomX Presents In Vivo Data on Bacteriophage Delivery to Intra-Tumor Bacteria
Sep 27, 2019
Aridis Pharmaceuticals to Present AR-105 and AR-501 (Gallium Citrate) Data at IDWeek(TM) 2019
Sep 25, 2019
Qpex Biopharma to Present its Anti-infective Portfolio at IDWeek 2019
Sep 12, 2019
Armata Pharmaceuticals Announces Development of New Synthetic Phage Candidate Targeting Pseudomonas aeruginosa
Sep 03, 2019
Aridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa
Jul 19, 2019
ID Genomics' CLoNeT E. coli Assay in Development to Combat Antibiotic Resistant Urinary Tract Infections